Novel systems for controlled delivery of macromolecules

Critical Reviews in Eukaryotic Gene Expression

Volumn 6, Issue 1, 1996, Pages 59-73

  Kuo, Patricia Y P ^a   Saltzman, W Mark ^a  

^a Johns Hopkins University   (United States)

Author keywords

controlled release; drug transport; gene therapy; liposomes; macromolecules; polymers

Indexed keywords

LIPOSOME; POLYMER;

ANIMAL CELL; DNA CONTENT; DRUG DELIVERY SYSTEM; DRUG TRANSPORT; GENE TARGETING; GENE THERAPY; GENE TRANSFER; GENETIC DISORDER; MACROMOLECULE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RECOMBINANT DNA TECHNOLOGY; REVIEW; SUSTAINED RELEASE PREPARATION; TARGET CELL;

ANIMALIA;

EID: 0029876486     PISSN: 10454403     EISSN: None     Source Type: Journal    
DOI: 10.1615/CritRevEukarGeneExpr.v6.i1.40     Document Type: Review

References (149)

1. Abuchowski A, van Es T, Palczuk NC, McCoy JR, Davis FF (1979): Treatment of L5178Y tumor-bearing BDF1 mice with a nonimmunogenic L-glutaminase-L-asparaginase. Cancer Treat Rep 63(6):1127-1132.
2. Adrian G, Huang L (1979): Entrapment of proteins in phosphatidylcholine vesicles. Biochemistry 18(25):5610-5614.
3. Allcock HR (1990): Polyphosphazenes as new biomedical and bioactive materials. In "Biodegradable Polymers as Drug Delivery Systems." Chasin M, Langer R, (eds): New York: Marcel Dekker, Inc. 163-193.
4. Arshady R (1990): Preparation of biodegradable microspheres and microcapsules. II. Polylactides and related polyesters. J Control Release 17:1-22.
5. Bangham A, Standish M, Watkins J (1965): Diffusion of univalent ions across the lamellae of swollen phospholipids. J Mol Biol 13:238-252.
6. Barr E, Leiden J (1991): Systemic delivery of recombinant proteins by genetically modified myoblasts. Science 254:1507-1509.
7. Beaty CE, Saltzman WM (1993): Controlled growth factor delivery induces differential neurite outgrowth in three-dimensional cell cultures. J Control Release 24:15-23.
8. Beck LR, Cowsar DR, Lewis DH, Gibson JW, Flowers CE (1979): New long-acting injectable microcapsule contraceptive system. Am J Obstet Gynecol 135:419-426.
9. Braatz JA, Yasuda Y, Olden K, Yamada KM, Heifetz AH (1993): Functional peptide-polyurethane conjugates with extended circulatory half-lives. Bioconjugate Chem 4:262-267.
10. Brem H, Piantadosi S, Burger PC, et al. (1995): Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. Lancet 345:1008-1012.
11. Brown L, Siemer L, Munoz C, Edelman E, Langer R (1986): Controlled release of insulin from polymer matrices: control of diabetes in rats. Diabetes 35:692-697.
12. Brown LR, Wei CL, Langer R (1983): In vivo and in vitro release of macromolecules from polymeric drug delivery system. J Pharmaceut Res 72:1181-1185.
13. Camarata PJ, Suryanarayanan R, Turner DA (1992): Sustained release of nerve growth factor from biodegradable polymer microspheres. Neurosurgery 30:313-319.
14. Canonico A, Plitman J, Conary J, Meyrick B, Brigham K (1994): No lung toxicity after repeated aerosol or intravenous delivery of plasmid-cationic liposome complexes. J Appl Physiol 77(1):415-419.
15. Challacombe S, Rahman D, Jeffery H, Davis S, O'Hagan D (1992): Enhanced secretory IgA and Systemic IgG antibody responses after oral immunization with biodegradable microparticles containing antigen. Immunology 76:164-168.
16. Chang P, Shen N, Westcott A (1993): Delivery of recombinant gene products with microencapsulated cells in vivo. Hum Gene Ther 4:433-440.
17. Chasin M, Hollenbeck G, Brem H, Grossman S, Colvin M, Langer R (1990): Interstitial drug therapy for brain tumors: a case study. Drug Dev Indust Pharm 16:2579-2594.
18. Chavany C, Le Doan T, Couvreur P, Puisieux F, Helene C (1992): Polyalkylcyanoacrylate nanoparticle as polymeric carriers for antisense oligonucleotides. Pharmaceut Res 9(4):441-449.
19. Cima L, Vacanti J, Vacanti C, Ingber D, Mooney D, Langer R (1991): Tissue engineering by cell transplantation using degradable polymer substrates. J Biomechan Eng 113(2):143-151.
20. Cleland J, Duenas E, Daughterly A, et al. (1995): Characterization of recombinant human growth hormone-PLGA formulations in animals. Proc Int Symp Control Rel Bioact Mater 22:143-144.
21. Cleland J, Powell M, Lim A, Barrón L, Berman P, Eastman D, Nunberg J, Wrin T, Vennari J (1994): Development of a single-shot subunit vaccine for HIV-1. AIDS Res Hum Retroviruses 10:S21-S25.
22. Cohen S, Yoshioka T, Lucarelli M, Hwang L, Langer R (1991): Controlled delivery systems for proteins based on poly(lactic/glycolic acid) microspheres. Pharmaceut Res 8:713-720.
23. Cooper M, Hansbrough J, Spielvogel R, Cohen R, Bartel R, Naughton G (1991): In vivo optimization of a living dermal substitute employing cultured human fibroblasts on a biodegradable polyglycolic acid or polyglactin mesh. Biomaterials 12(2):243-248.
24. Cudd A, Nicolau C (1984): Liposome. In Gregoriadis F, (ed) "Liposome Technology." Boca Raton: CRC Press, 207-221.
25. Cullis P, deKruijff B (1979): Lipid polymorphism and the functional roles of lipids in biological membranes. Biochim Biophys Acta 559(4):399-420.
26. Culver K, Cornett K, Morgan R, et al. (1991): Lymphocytes as cellular vehicles for gene therapy in mouse and man. Proc Nail. Acad Sci USA 88:3155-3159.
27. Dang W, Saltzman WM (1992): Dextran retention in the rat brain following controlled release from a polymer. Biotechnol Prog 8:527-532.
28. Dang W, Saltzman WM (1994): Controlled release of macromolecules from a biodegradable polyanhydride matrix. J Biomater Sci Polym Ed 6(3):291-311.
29. Dang WB, Colvin OM, Brem H, Saltzman WM (1994): Covalent coupling of methotrexate to dextran enhances the penetration of cytotoxicity into a tissue-like matrix. Cancer Res 54:1729-1735.
30. Debruyne F, Denis L, Lunglmayer G, et al. (1988): Long-term therapy with a depot luteinizing hormone-releasing-hormone analogue (Zoladex) in patients with advanced prostatic carcinoma. J Urol 140:757-777.
31. Dhawan J, Pan L, Pavlath G, Travis M, Lanctot A, Blau H (1991): Systemic delivery of human growth hormone by injection of genetically engineered myoblasts. Science 254:1509-1512.
32. Duncan R (1992): Drug-polymer conjugates: potential for improved chemotherapy. Anti-Cancer Drugs 3:175-210.
33. Duncan R, Hume I, Yardley H, Flanagan P, Ulbrich K, Subr V, Strohalm J (1991): Macromolecular prodrugs for use in targeted cancer chemotherapy: melphalan covalently coupled to N-(2-hydroxypropyl) methacrylamid copolymers. J Control Release 16:121-136.
34. During MJ, Sabel BA, Freese A, Saltzman WM, Deutz A, Roth RH, Langer R (1989): Controlled release of dopamine from a polymeric brain implant: in vivo characterization. Annal Neurol 25:351-356.
35. Dzierzak E, Papayannopoulou T, Mulligan R (1988): Lineage-specific expression of a human betaglobin in murine bone marrow transplant recipients reconstituted with retrovirus transduced stem cells. Nature (London) 331:35-41.
36. Edelman E, Adams D, Karnovsky M (1990): Effect of controlled adventitial heparin delivery on smooth muscle cell proliferation following endothelial injury. Proc Natl Acad Sci USA 87:3773-3777.
37. Edelman ER, Mathiowitz E, Langer R, Klagsbrun M (1991): Controlled and modulated release of basic fibroblast growth factor. Biomaterials 12:619-626.
38. Eldridge J, Hammond C, Meulbroek J, Staas J, Gilley R, Tice T (1990): Controlled vaccine release in the gut-associated lymphoid tissues. I. Orally administered biodegradable microspheres target the Peyer's patches. J Control Release 11:205-214.
39. Emerich DF, Hammang JP, EEB, Winn SR (1994): Implantation of polymer-encapsulated human nerve growth factor-secreting fibroblasts attenuates the behavioral and neuropathological consequences of quinolinic acid injections into rodent striatum. Exp Neurol 130:141-150.
40. Feigner P, Gadek T, Holm M, Roman R, Chan H, Wenz M, Northrop J, Ringold G, Danielsen M (1987): Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. Proc Natl Acad Sci USA 84:7413-7417.
41. Feigner P, Ringold G (1989): Cationic liposome-mediated transfection. Nature 337(26):387-388.
42. Fischel-Ghodsian F, Brown L, Mathiowitz E, Brandenburg D, Langer R (1988): Enzymatically controlled drug delivery. Proc Nl Acad Sci USA 85:2403-2406.
43. Flowers M, Stockschlaeder M, Schuening F, Nieder-Wieser D, Hackman R, Miller A, Storb R (1990): Long-term transplantation of canine keratinocytes made resistant to G418 through retrovirus-mediated gene transfer. Proc Natl Acad Sci USA 87:2349-2353.
44. Folkman J, Long D (1964): The use of silicone rubber as a carrier for prolonged drug therapy. J Surg Res 4:139-142.
45. Fraley R, Subraman S, Berg P, Papahadjopoulos D (1980): Introduction of liposome-encapsulated SV40 DNA into cells. J Biol Chem 255(21):10431-10435.
46. Freed L, Marquis J, Nohria A, Emmanual J, Mikos A, Langer R (1993): Neocartilage formation in vitro and in vivo using cells cultured on synthetic biodegradable polymers. J Biomed Mater Res 27:11-23.
47. Friedmann T (1989): Progress toward human gene therapy. Science 244:1275-1281.
48. Fung L, Shin M, Tyler B, Brem H, Saltzman WM (in press): Chemotherapeutic drugs released from polymers: distribution of 1,3-bis(2-chloroethyl)-1-nitrosourea in the rat brain. Pharmaceutical Research.
49. Gilbert J, Takada T, Stein J, Langer R, Vacanti J (1993): Cell transplantation of genetically altered cells on biodegradable polymer scaffolds in syngeneic rats. Transplantation 56(2):423-427.
50. Goldspiel B, Green L, Calis K (1993): Human gene therapy. Clin Pharm 12(7):488-505.
51. Gombotz WR, Healy MS, Brown LR (1991): Very low temperature casting of controlled release microspheres. United States, Enzytech, Inc.
52. Gref R, Minamitake Y, Peracchia M, Trubetskoy V, Torchilin V, Langer R (1994): Biodegradable long-circulating polymeric nanospheres. Science 263:1600-1603.
53. Haensler J, Szoka FJ (1993): Polyamidoamine cascade polymers mediate efficient transfection of cells in culture. Bioconjug Chem 4(5):372-379.
54. Hansbrough J, Cooper M, Cohen R, Spielvogel R, Greenleaf G, Bartel R, Naughton G (1992): Evaluation of abiodegradable matrix containing cultured human fibroblasts as a dermal replacement beneath meshed skin grafts on athymic mice. Surgery 111(4):438-446.
55. Heller J (1990): Development of poly(ortho esters): a historical overview. Biomaterials 11:659-665.
56. Hershfield MS, Buckley RH, Greenberg ML, et al. (1987): Treatment of adenosine deaminase deficiency with polyethylene glycol-modified adenosine deaminase. N Engl J Med 316(10):589-596.
57. Hoffman D, Wahlberg L, Aebischer P (1990): NGF Released from a polymer matrix prevents loss of ChAT expression in basal forebrain neurons following a fimbria-fornix lesion. Exp Neurol 110:39-44.
58. Hora MS, Rana RK, Nunberg JH, Tice TR, Gilley RM, Hudson ME (1990): Controlled release of Interleukin-2 from biodegradable microspheres. Bio/Technology 8(August 1990):755-758.
59. Howard M, Gross A, Grady M, Langer R, Mathiowitz E, Winn R, Mayberg M (1989): Intracerebral drug delivery in rats with lesion-induced memory deficits. J Neurosurg 71:105-112.
60. Hudecz F, Clegg JA, Kajtar J, Embleton MJ, Pimm MV, Szekerke M, Baldwin RW (1993): Influence of carrier on biodistribution and in vitro cytotoxicity of methotrexate-branched polypeptide conjugates. Bioconjugate Chem 4:25-33.
61. Joseph JM, Goddard MB, Mills J, et al. (1994): Transplantation of encapsulated bovine chromaffin cells in the sheep subarachnoid space: a preclinical study for the treatment of cancer pain. Cell Transplant 3:355-364.
62. Katre NV, Knauf MJ, Laird WJ (1987): Chemical modification of recombinant interleukin 2 by polyethylene glycol increases its potency in the murine Meth A sarcoma model. Proc Natl Acad Sci USA 84:1487-1491.
63. Knowles MR, Hohneker KW, Zhou Z, Olsen JC, Noah TL, Hu P-C, Leigh MW, Engelhardt JF, Edwards LJ, Jones KR, Grossman M, Wilson JM, Johnson LG, Boucher RC (1995): A controlled study of adenoviral-vector-mediated gene transfer in the nasal epithelium of patients with cystic fibrosis. N Engl J Med 333:823-831.
64. Kopecek J (1990): The Potential of Water-Soluble Polymeric Carriers in Targeted and Site-Specific Drug Delivery. J Control Rel 11:279-290.
65. Krewson CE, Klarman M, Saltzman WM (1995): Distribution of nerve growth factor following direct delivery to brain interstitium. Brain Res 680:196-206.
66. Langer R (1990): New methods of drug delivery. Science 249:1527-1533.
67. Langer R, Folkman J (1976): Polymers for the sustained release of proteins and other macromolecules. Nature 263:797-800.
68. Langer R, Moses M (1991): Biocompatible controlled release polymers for delivery of polypeptides and growth factors. J Cell Biochem 45:340-345.
69. Lasic D (1992): Liposomes. Am Sci 80:20-31.
70. Laurencin C, Gerhart T, Witschger P, et al. (1993): Bioerodible polyanhydrides for antibiotic drug delivery: in vivo osteomyelitis treatment in a rat model system. J Orthopaed Res 11(2):256-262.
71. Ledley F, Darlington G, Hahn T, Woo S (1987): Retroviral gene transfer into primary hepatocytes: implications for genetic therapy of liver-specific functions. Proc Natl Acad Sci USA 84:5335-5339.
72. Lee A, Langer R (1983): Shark cartilage contains inhibitors of tumor angiogenesis. Science 221:1185-1187.
73. Leong K, Brott B, Langer R (1985): Bioerodible polyanhydrides as drug-carrier matrices. I. Characterization, degradation and release characteristics. J Biomed Mater Res 19:941-955.
74. Lewis DH (1990): Controlled release of bioactive agents from lactide/glycolide polymers. In "Biodegradable Polymers as Drug Delivery Systems." Chasin M, Langer R (eds): New York: Marcel Dekker, Inc. 1-42.
75. Li C, Dwarki V, Verma I (1990): Expression of human alpha-globin and mouse/human hybrid beta-globin genes in murine hematopoietic stem cells transduced by recombinant retrovirus. Proc Natl Acad Sci USA 87:4349-4353.
76. Litzinger D, Huang L (1992): Phosphatidylethanolamine liposomes: drug delivery, gene transfer and immunodiag-nostic applications. Biochim Biophys Acta 1113:201-227.
77. Lyerly H, DiMaio J (1993): Gene delivery systems in surgery. Arch Surg 128(11):1197-1206.
78. Malone R, Feigner P, Verma I (1989): Cationic liposome-mediated RNA transfection. Proc Natl Acad Sci USA 86(16):6077-6081.
79. Marx PA, Compans RW, Gettie A, Staas JK, Gilley RM, Mulligan MJ, Yamshchikov GV, Chen D, Eldridge JH (1993): Protection against vaginal SIV transmission with microencapsulated vaccine. Science 260:1323-1327.
80. Mathiowitz E, Saltzman WM, Domb A, Dor P, Langer R (1988): Polyanhydride microspheres as drug carriers. II. Microencapsulation by solvent removal. J Appl Polym Sci 35:755-774.
81. Mendell JR, Kissel JT, Amato AA, King W, Signore L, Prior TW, Sahenk E, Benson S, McAndrew PE, Rice R, Nagaraja H, Stephens R, Lantry L, Morris GE, Burghes AHM (1995): Myoblast transfer in the treatment of Duchenne's muscular dystrophy. N Engl J Med 33:832-838.
82. Molteni L (1979): Dextrans as carriers. In Gregoriadis G (ed): "Drug Carriers in Biology and Medicine." New York: Academic Press.
83. Murray J, Brown L, Langer R, Klagsbum M (1983): A micro sustained release system for epidermal growth factor. In Vitro 19:743-748.
84. Nathan A, Zalipsky S, Ertel SI, Agathos SN, Yarmuch ML, Kohn J (1993): Copolymers of lysine and polyethylene glycol: a new family of functionalized drug carriers. Bioconjugate Chem 4(1):54.
85. Naughton B, Dai Y, Sibanda B, Scharfmann R, San Roman J, Zeigler F, Verma I (1992): Long-term expression of a retrovirally introduced β-galactosidase gene in rodent cells implanted in vivo using biodegradable polymer meshes. Somat Cell Mol Genet 18(5):451-462.
86. O'Hagan DT, Rahman D, McGee JP, Jeffery H, Davies MC, Williams P, Davis SS, Challacombe SJ (1991): Biodegradable microparticles as controlled release antigen delivery systems. Immunology 73(239-242):
87. O'Neal W, Beaudet A (1994): Somatic gene therapy for cystic fibrosis. Hum Mol Genet 3:1497-1502.
88. Oku N (1991): Liposomes. In Dunn R, Ottenbrite R (eds): "Polymeric Drugs and Drug Delivery Systems." Washington, DC: ACS Symposium Series, 24-33.
89. Papahadjopoulos D, Allen T, Gabizon A, et al. (1991): Sterically stabilized liposomes: pronounced improvements in blood clearance, tissue distribution and therapeutic index of encapsulated drugs against implanted tumors. Proc Natl Acad Sci USA 88:11460-11464.
90. Patel H (1984): Liposomes: bags of challenge. Biochem Soc Trans 12:333-335.
91. Perales J, Ferkol T, Molas M, Hanson R (1994): An evaluation of receptor-mediated gene transfer using synthetic DNA-ligand complexes. Eur J Biochem 226(2):255-266.
92. Pitt CG, Marks TA, Schlinder A (1980): Biodegradable drug delivery systems based on aliphatic polymers: application to contraceptives and narcotic antagonists. In Baker RW (ed): "Controlled Release of Bioactive Compounds." New York: Academic Press, 19-43.
93. Powell EM, Sobarzo MR, Saltzman WM (1990): Controlled release of nerve growth factor from a polymeric implant. Brain Res 515:309-311.
94. Pries I, Langer R (1979): A single-step immunization by sustained antigen release. J Immunol Methods 28:193-197.
95. Pulapura S, Li C, Kohn J (1990): Structure-property relationships for the design of polyiminocarbonates. Biomaterials 11:666-678.
96. Radomsky ML, Whaley KJ, Cone RA, Saltzman WM (1990): Macromolecules released from polymers: diffusion into unstirred fluids. Biomaterials 11:619-624.
97. Radomsky ML, Whaley KJ, Cone RA, Saltzman WM (1992): Controlled vaginal delivery of antibodies in the mouse. Biol Reproduct 47:133-140.
98. Richards M, Dahiyat BI, Arm DM, Brown PR, Leong KW (1991): Evaluation of polyphosphates and polyphosphonates as degradable materials. J Biomed Mater Res 25:1151-1167.
99. Ringsdorf H (1975): Structure and properties of pharmacologically active polymers. J Polym Sci Polym Symp 51:135-153.
100. Rosen H, Chang J, Wnek G, Linhardt R, Langer R (1983): Bioerodible polyanydrides for controlled drug delivery. Biomaterials 4:131-133.
101. Ryman B, Jewkes R, Jeyasingh K, Osborne M, Patel H. Richardson V, Tattersall M, Tyrrell D (1978): Potential applications of liposomes to therapy. Annal NY Acad Sci 308:281-306.
102. Salehi-Had S, Saltzman WM (1994): Controlled intracranial delivery of antibodies in the rat. In Cleland J, Langer R (eds): "Protein Formulations and Delivery." Washington, D.C.: ACS Symposium Series, 278-291.
103. Saltzman WM (1993): Antibodies for treating and preventing disease: the potential role of polymeric controlled release. Crit Rev Therapeut Drug Carrier Syst 10(2):111-142.
104. Saltzman WM, Langer R (1989): Transport rates of proteins in porous polymers with known microgeometry. Biophys J 55:163-171.
105. Saltzman WM, Radomsky ML (1991): Drugs released from polymers: diffusion and elimination in brain tissue. Chem Eng Sci 46:2429-2444.
106. Sanders L, Kell BA, McRae GI, Whitehead GW (1986): Prolonged controlled release of Naferlin, a luteinizing hormone-releasing hormone analogue, from biodegradable polymeric implants. J Pharmaceut Sci 75:356-360.
107. Sawhney AS, Pathak CP, Hubbell JA (1994): Modification of islet of Langerhans surfaces with immunoprotective poly(ethylene glycol) coatings via interfacial polymerization. Biotechnol Bioeng 44:383-386.
108. Schacht E (1987): Polysaccharide macromolecules as drug carriers. In Ilium L, Davis SS (eds): "Polymers in Controlled Drug Delivery." Bristol: Wright, 131-187.
109. Schaefer-Ridder M. Wang Y, Hofschneider P (1982): Liposomes as gene carriers: efficient transformation of mouse L cells by thymidine kinase gene. Science 215:166-168.
110. Scharfmann R, Axelrod J, Verma I (1991): Long-term in vivo expression of retrovirus-mediated gene transfer in mouse fibroblast implants. Proc Natl Acad Sci USA 88(11):4626-4630.
111. Seddon J, Kaye R, Marsh D (1983): Induction of the lamellar-inverted hexagonal phase-transition in cardiolipin by protons and mono-valent cations. Biochim Biophys Acta 734(2):347-352.
112. Sherwood JK, Dause RB, Saltzman WM (1992): Controlled antibody delivery systems. Bio/Technology 10:1446-1449.
113. Sherwood JK, Zeitlin L, Whaley KJ, Cone RA, Saltzman WM (1996): Controlled release of antibodies for long-term topical passive immunoprotection of female mice against genital herpes. Nature Biotechnology, in press.
114. Short M, Choi B, Lee J, Malick A, Breakefield X, Martuza R (1990): Gene delivery to glioma-cells in rat-brain by grafting of a retrovirus packaging cell-line. J Neurosci Res 27(3):427-433.
115. Sidman KR, Schwope AD, Steber WD, Rudolph SE, Poulin SB (1980): Biodegradable, implantable sustained release systems based on glutamic acid copolymers. J Membr Sci 7:277-291.
116. Sivin I (1988): International Experience with NORPLANT and NORPLANT-2 Contraceptives. Stud Family Plan 19:81-94.
117. Sorscher E, Logan J, Frizzell R, et al. (1994): Gene therapy for cystic fibrosis using cationic liposome mediated gene transfer: a phase I trial of safety and efficacy in the nasal airway. Hum Gene Ther 5(10):1259-1277.
118. St. Louis D, Verma I (1988): An alternative approach to somatic cell gene therapy. Proc Natl Acad Sci USA 85:3150-3154.
119. Stannett VT, Koros WJ, Paul DR, Lonsdale HK, Baker RW (1979): Recent advances in membrane science and technology. Advan Polym Sci 32:69-121.
120. Stewart M, Plautz G, Del Buono L, Yang Z, Xu L, Gao X, Huang L, Nabel E, Nabel G (1992): Gene transfer in vivo with DNA-liposome complexes: safety and acute toxicity in mice. Hum Gene Ther 3:267-275.
121. Stieneker F, Kreuter J (1994): Nanoparticles as a potential antigen delivery system. In Cleland J, Langer R (eds): "Protein Formulations and Delivery." Washington D.C.: ACS Symposium Series, 306-321.
122. Strasser JF, Fung L, Eller S, Grossman SA, Saltzman WM (1995): Distribution of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) and tracers in the rabbit brain following interstitial delivery by biodegradable polymer implants. J Pharmacol Exp Ther 275:1647-1655.
123. Stribling R, Brunette E, Liggit D, Gaensler K, Debs R (1992): Aerosol gene delivery in vivo. Proc Natl Acad Sci USA 89(23):11277-11281.
124. Szelei J, Duda E (1989): Entrapment of high-molecular-mass DNA-molecules in liposomes for the genetic-transformation of animal-cells. Biochem J 259(2):549-553.
125. Szoka F, Papahadjopoulos D (1978): Procedure for preparations of liposomes with large internal aqueous space and high capture by reverse phase evaporation. Proc Natl Acad Sci USA 75:4194-4198.
126. Tai I, Sun A (1993): Microencapsulation of recombinant cells: a new delivery system for gene therapy. FASEB J 7:1061-1069.
127. Tamada J, Langer R (1992): Review: the development of polyanhydrides for drug delivery. J Biomater Sc Polym Ed 3(4):315-353.
128. Teppler H, Kaplan G, Smith KA, Montana AL, Meyn P, Cohn ZA (1993): Prolonged immunostimulatory effect of low-dose polyethylene glycol interleukin 2 in patients with human immunodeficiency virus type 1 infection. J Exp Med 177:483-492.
129. Trivedi R, Dickson G (1995): Liposome-mediated gene transfer into normal and dystrophin-deficient mouse myoblasts. J Neurochem 64(5):2230-2238.
130. Truong V, Guarnieri F, Hildreth J, Williams J, August J, Leong K (1994): Immuno-microsphers as gene delivery vehicle: targeting of LAMP-1 to lysosomal membrane. Proc Int Symp Control Rel Bioact Mater 21:142-143.
131. Truong V, Walsh S, August J, Leong K (1995): Gene transfer by gelatin-DNA coacervate. Proc Int Symp Control Rel Bioact Mater 22:466-467.
132. Vacanti CA, Langer R, Schloo B, Vacanti JP (1991): Synthetic polymers seeded with chondrocytes provide a template for new cartilage formation. Plastic Reconstruct Surg 88:753-759.
133. Vacanti JP, Morse M, Domb A, Saltzman WM, Perez-Atayde A, Langer R (1988): Selective cell transplantation using bioabsorbable artificial polymers as matrices. J Pediatr Surg 23:3-9.
134. Verkleij A (1984): Lipidic intramembranous particles. Biochim Biophys Acta 779(1):43-63.
135. Versland M, Wu C, Wu G (1992): Strategies for gene therapy in the liver. Semin Liver Dis 12(3):332-339.
136. Vieweg J, Boczkowski D, Roberson K, et al. (1995): Efficient gene transfer with adeno-associated virus-based plasmids complexed to cationic liposomes for gene therapy of human prostate cancer. Cancer Res 55(11):2366-2372.
137. von der Leyen H, Gibbons G, Morishita R, Lewis N, Zhang L, Nakajima M, Kaneda Y, Cooke J, Dzau V (1995): Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene. Proc Natl Acad Sci. USA 92(4):1137-1141.
138. Wagner E, Zenke M, Cotten M, Beug H, Birnstiel M (1990): Transferrin-polycation conjugates as carriers for DNA uptake into cells. Proc Natl Acad Sci USA 87:3410-3414.
139. Wang C, Huang L (1987): pH-sensitive immunoliposomes mediate target-cell-specific delivery and controlled expression of a foreign gene in mouse. Proc Natl Acad Sci USA 84(22):7851-7855.
140. Wang C, Huang L (1989): Highly efficient DNA delivery mediated by pH-sensitive immunoliposomes. Biochemistry 28:9508-9514.
141. Whittum-Hudson J, Saltzman W, O'Brien T, Prendergast R, MacDonald A (1995): Oral immunization with antiidiotypic antibodies protects against ocular chlamydial infection. Investigat Ophthalmol Visual Sci 36 (Suppl):S1030.
142. Wilson J, Birinyi L, Salomon R, Libby P, Callow A, Mulligan R (1989): Implantation of vascular grafts lined with genetically modified endothelial cells. Science 244(4910):1344-1346.
143. Wilson J, Danos O, Grossman M, Raulet D, Mulligan R (1990): Expression of human adenosine deaminase in mice reconstituted with retrovirus-transduced hematopoietic stem cells. Proc Natl Acad Sci USA 87:439-443.
144. Winn SR, Hammang JP, Emerich DF, Lee A, Palmiter RD, Baetge EE (1994): Polymer-encapsulated cells genetically modified to secrete human nerve growth factor promote the survival of axotomized septal cholinergic neurons. Proc Natl Acad Sci USA 91:2324-2328.
145. Wolff J, Malone R, Williams P, Chong W, Acsadi G, Jani A, Feigner P (1990): Direct gene transfer into mouse muscle in vivo. Science 247:1465-1468.
146. Wyatt TL, Whaley KJ, Cone RA, Saltzman WM (1993): Controlled vaginal delivery of antigens to stimulate mucosal immunity. Proc Int Symp Control Rel Bioact Mater 20:61-62.
147. Yolles S, Eldridge JE, Woodland JHR (1970): Sustained delivery of drugs from polymer/drug mixtures. Polym News 1:9.
148. Yoshimura K, Rosenfeld M, Nadamura H, Scherer E, Pavirani A, Lecocq J-P, RG C (1992): Expression of human cystic fibrosis transmembrane conductance regulator gene in the mouse lung after in vivo intratracheal plasmid-mediated gene transfer. Nucl Acids Res 20(2):3233-3240.
149. Zhu N, Liggitt D, Liu Y, Debs R (1993): Systemic gene expression after intravenous DNA delivery into adult mice. Science 261:209-211.